Development and Validation of the LIFE‐5S Score for Predicting 5‐Year Mortality After Transvenous Lead Extraction
Journal of Cardiovascular Electrophysiology · 2026-11 · 37 (11) · 2452-2464
DOI: 10.1111/jce.70427 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 08.07.2026. Verfasst von Wojciech Jacheć und 3 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. Hauptthemen laut MEDLINE: Device Lead Extraction, Device Removal, Defibrillators, Implantable, Decision Support Techniques. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Medical University of Silesia, Śląski Uniwersytet Medyczny.
Abstract (Originalsprache)
Introduction
Long‐term mortality after transvenous lead extraction (TLE) remains substantial despite high procedural success. However, simple tools for estimating long‐term prognosis after successful TLE are lacking. Methods and Results This retrospective multicenter study included 3368 consecutive patients undergoing TLE between 2006 and 2020 with complete 5‐year follow‐up. Patients were assigned in a 1:1 ratio to derivation and validation cohorts ( n = 1684 each). Independent predictors of mortality were identified using multivariable Cox proportional hazards analysis and incorporated into a point‐based risk score, the List of Independent Factors for Estimated 5‐Year Survival (LIFE‐5S). During follow‐up, cumulative 5‐year mortality was 32.2%. Independent predictors included male sex, older age, permanent atrial fibrillation, advanced heart failure (NYHA class III/IV), type 2 diabetes, renal dysfunction, reduced left ventricular ejection fraction, pocket infection, lead‐related infective endocarditis, and the presence of cardiac resynchronization therapy. Each 1‐point increase in the LIFE‐5S score was associated with higher mortality risk (HR 1.36, 95% CI 1.33–1.39; p < 0.001). The model demonstrated good discrimination (AUC 0.786 in the derivation cohort and 0.785 in the validation cohort) and good calibration across score strata. To facilitate clinical application, an online calculator based on the LIFE‐5S model is available ( https://usuwanieelektrod.pl/life5scalculator ).
Conclusion
The LIFE‐5S score provides a simple bedside tool for long‐term prognostic stratification after TLE. This model may support clinical decision‐making, patient counseling, and planning of individualized follow‐up strategies after TLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
- Department of Cardiac Surgery, The Pope John Paul II Province Hospital, Zamość, Poland.
- Faculty of Health Sciences, Academy of Zamość, Zamość, Poland.
ORCID-Profile: Dorota Nowosielecka, Andrzej Kutarski
Förderung
- Medical University of Silesia
- Śląski Uniwersytet Medyczny
Zitieren
APA
Jacheć, W., Tułecki, Ł., Nowosielecka, D., & Kutarski, A. (2026). Development and Validation of the LIFE‐5S Score for Predicting 5‐Year Mortality After Transvenous Lead Extraction. Journal of Cardiovascular Electrophysiology, 37(11), 2452-2464. https://doi.org/10.1111/jce.70427
Vancouver
Jacheć W, Tułecki Ł, Nowosielecka D, Kutarski A. Development and Validation of the LIFE‐5S Score for Predicting 5‐Year Mortality After Transvenous Lead Extraction. Journal of Cardiovascular Electrophysiology. 2026;37(11):2452-2464. doi:10.1111/jce.70427
BibTeX
@article{Jache2026,
author = {Jacheć, Wojciech and Tułecki, Łukasz and Nowosielecka, Dorota and Kutarski, Andrzej},
title = {Development and Validation of the LIFE‐5S Score for Predicting 5‐Year Mortality After Transvenous Lead Extraction},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {11},
pages = {2452--2464},
doi = {10.1111/jce.70427}
}
EUVIMED